Cooper Companies (NASDAQ:COO) Now Covered by The Goldman Sachs Group

Key Points

• Goldman Sachs initiated coverage on Cooper Companies with a "sell" rating, adding to mixed analyst sentiments regarding the company’s stock.
• The company’s recent quarterly earnings surpassed estimates, reporting $1.10 earnings per share, a slight increase from the previous year’s $0.96 EPS, amidst a revenue growth of 5.7%.
• Cooper Companies announced a $2 billion stock repurchase plan, indicating confidence from management in the value of the company's shares.

Research analysts at The Goldman Sachs Group started coverage on shares of Cooper Companies (NASDAQ:COO - Get Free Report) in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The brokerage set a "sell" rating on the medical device company's stock.

Other equities analysts also recently issued reports about the company. Piper Sandler lowered their price objective on Cooper Companies from $105.00 to $83.00 and set an "overweight" rating for the company in a research report on Thursday, August 28th. Stifel Nicolaus decreased their target price on Cooper Companies from $90.00 to $85.00 and set a "buy" rating for the company in a research note on Thursday, August 28th. UBS Group raised Cooper Companies to a "buy" rating in a research note on Tuesday, June 17th. Wells Fargo & Company decreased their target price on Cooper Companies from $93.00 to $72.00 and set an "overweight" rating for the company in a research note on Thursday, August 28th. Finally, Mizuho decreased their target price on Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a research note on Wednesday, July 16th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $84.75.

Cooper Companies Price Performance

Shares of COO opened at $69.12 on Wednesday. Cooper Companies has a 1 year low of $61.78 and a 1 year high of $109.37. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The company has a market capitalization of $13.74 billion, a price-to-earnings ratio of 34.05, a price-to-earnings-growth ratio of 1.79 and a beta of 1.02. The business has a 50-day moving average of $69.77 and a 200-day moving average of $74.22.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.07 by $0.03. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The company had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same period last year, the company earned $0.96 earnings per share. The firm's revenue was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, equities research analysts anticipate that Cooper Companies will post 3.98 earnings per share for the current year.

Cooper Companies declared that its Board of Directors has approved a stock repurchase plan on Wednesday, September 17th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the medical device company to repurchase up to 15.4% of its stock through open market purchases. Stock buyback plans are generally a sign that the company's management believes its shares are undervalued.

Insider Activity

In related news, COO Gerard H. Warner III purchased 1,450 shares of Cooper Companies stock in a transaction that occurred on Friday, September 5th. The shares were acquired at an average cost of $69.23 per share, for a total transaction of $100,383.50. Following the transaction, the chief operating officer directly owned 18,319 shares in the company, valued at $1,268,224.37. The trade was a 8.60% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Daniel G. Mcbride purchased 3,000 shares of Cooper Companies stock in a transaction that occurred on Tuesday, September 2nd. The shares were bought at an average price of $65.04 per share, for a total transaction of $195,120.00. Following the completion of the transaction, the chief operating officer owned 63,120 shares in the company, valued at $4,105,324.80. The trade was a 4.99% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders purchased 17,975 shares of company stock worth $1,216,346. 1.98% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Cooper Companies

Several institutional investors and hedge funds have recently bought and sold shares of the business. UMB Bank n.a. grew its holdings in Cooper Companies by 16.7% during the 1st quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock worth $76,000 after acquiring an additional 129 shares in the last quarter. Horizon Investments LLC grew its holdings in Cooper Companies by 5.0% during the 1st quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company's stock worth $241,000 after acquiring an additional 136 shares in the last quarter. Axxcess Wealth Management LLC grew its holdings in Cooper Companies by 1.9% during the 1st quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company's stock worth $623,000 after acquiring an additional 140 shares in the last quarter. Wealth Alliance LLC grew its holdings in Cooper Companies by 4.2% during the 2nd quarter. Wealth Alliance LLC now owns 4,230 shares of the medical device company's stock worth $301,000 after acquiring an additional 171 shares in the last quarter. Finally, State of Michigan Retirement System grew its holdings in Cooper Companies by 0.4% during the 2nd quarter. State of Michigan Retirement System now owns 54,344 shares of the medical device company's stock worth $3,867,000 after acquiring an additional 200 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.